These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 24286081
1. Novel poly(L-lactide-co-ε-caprolactone) matrices obtained with the use of Zr[Acac]₄ as nontoxic initiator for long-term release of immunosuppressive drugs. Jelonek K, Kasperczyk J, Li S, Dobrzynski P, Janeczek H, Jarzabek B. Biomed Res Int; 2013; 2013():607351. PubMed ID: 24286081 [Abstract] [Full Text] [Related]
2. Controlled poly(l-lactide-co-trimethylene carbonate) delivery system of cyclosporine A and rapamycine--the effect of copolymer chain microstructure on drug release rate. Jelonek K, Kasperczyk J, Li S, Dobrzynski P, Jarzabek B. Int J Pharm; 2011 Jul 29; 414(1-2):203-9. PubMed ID: 21621596 [Abstract] [Full Text] [Related]
4. The influence of paclitaxel on hydrolytic degradation in matrices obtained from aliphatic polyesters and polyester carbonates. Musiał-Kulik M, Kasperczyk J, Jelonek K, Dobrzyński P, Gebarowska K, Janeczek H, Libera M. Acta Pol Pharm; 2010 Jul 29; 67(6):664-8. PubMed ID: 21229883 [Abstract] [Full Text] [Related]
6. The application of microspheres from the copolymers of lactide and epsilon-caprolactone to the controlled release of steroids. Buntner B, Nowak M, Kasperczyk J, Ryba M, Grieb P, Walski M, Dobrzyñski P, Bero M. J Control Release; 1998 Dec 04; 56(1-3):159-67. PubMed ID: 9801439 [Abstract] [Full Text] [Related]
7. Comparison of accelerated and real-time cyclosporine A release testing from poly(l-lactide-co-trimethylene carbonate) matrices. Jelonek K, Kasperczyk J, Dobrzyński P, Szczepka K, Janeczek H, Jarzabek B, Jaworska J, Smola A. Acta Pol Pharm; 2010 Dec 04; 67(6):722-4. PubMed ID: 21229896 [No Abstract] [Full Text] [Related]
12. Effect of the molecular weight of poly(epsilon-caprolactone-co-DL-lactide) on toremifene citrate release from copolymer/silica xerogel composites. Rich J, Kortesuo P, Ahola M, Yli-Urpo A, Kiesvaara J, Seppälä J. Int J Pharm; 2001 Jan 05; 212(1):121-30. PubMed ID: 11165827 [Abstract] [Full Text] [Related]
15. The influence of chain microstructure of biodegradable copolyesters obtained with low-toxic zirconium initiator to in vitro biocompatibility. Orchel A, Jelonek K, Kasperczyk J, Dobrzynski P, Marcinkowski A, Pamula E, Orchel J, Bielecki I, Kulczycka A. Biomed Res Int; 2013 Jan 05; 2013():176946. PubMed ID: 24062998 [Abstract] [Full Text] [Related]
16. Tailoring the PLATMC chain microstructure for stable cyclosporine A release. Kasperczyk J, Jelonek K, Gębarowska K, Dobrzyński P, Smola A. J Control Release; 2011 Nov 30; 152 Suppl 1():e42-4. PubMed ID: 22195915 [No Abstract] [Full Text] [Related]
17. Formulation of delivery systems with risperidone based on biodegradable terpolymers. Turek A, Borecka A, Janeczek H, Sobota M, Kasperczyk J. Int J Pharm; 2018 Sep 05; 548(1):159-172. PubMed ID: 29953927 [Abstract] [Full Text] [Related]